Moreover, analysis of 53 peripheral blood samples from individuals with type 2 diabetes mellitus (T2DM) showed that MEG3 is related to the progression of T2DM and can be used as a novel biomarker for clinical diagnosis (Chang et al., 2020). The gene discussed is MEG3; the disease is diabetes mellitus.